Martin JN - Search Results

1

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Deeks SG, et al. Among authors: martin jn. J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334. J Infect Dis. 2000. PMID: 10720517

2

Effect of older age on survival in human immunodeficiency virus (HIV) disease.

Martin JN, Colford JM Jr, Ngo L, Tager IB. Martin JN, et al. Am J Epidemiol. 1995 Dec 1;142(11):1221-30. doi: 10.1093/oxfordjournals.aje.a117581. Am J Epidemiol. 1995. PMID: 7485069

3

A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease.

Martin JN, Perdreau-Remington F, Kartalija M, Pasi OG, Webb M, Gerberding JL, Chambers HF, Täuber MG, Lee BL. Martin JN, et al. J Infect Dis. 1999 Sep;180(3):896-9. doi: 10.1086/314949. J Infect Dis. 1999. PMID: 10438389 Clinical Trial.

4

Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

Martin JN, Rose DA, Hadley WK, Perdreau-Remington F, Lam PK, Gerberding JL. Martin JN, et al. J Infect Dis. 1999 Dec;180(6):1809-18. doi: 10.1086/315132. J Infect Dis. 1999. PMID: 10558935

5

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

Kahn JO, Martin JN, Roland ME, Bamberger JD, Chesney M, Chambers D, Franses K, Coates TJ, Katz MH. Kahn JO, et al. Among authors: martin jn. J Infect Dis. 2001 Mar 1;183(5):707-14. doi: 10.1086/318829. Epub 2001 Feb 1. J Infect Dis. 2001. PMID: 11181146

6

Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient.

Deeks SG, Martin JN. Deeks SG, et al. Among authors: martin jn. AIDS. 2001 Jan 5;15(1):117-9. doi: 10.1097/00002030-200101050-00017. AIDS. 2001. PMID: 11192853 No abstract available.

7

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

Roland ME, Martin JN, Grant RM, Hellmann NS, Bamberger JD, Katz MH, Chesney M, Franses K, Coates TJ, Kahn JO. Roland ME, et al. Among authors: martin jn. J Infect Dis. 2001 Dec 15;184(12):1608-12. doi: 10.1086/324580. Epub 2001 Dec 3. J Infect Dis. 2001. PMID: 11740738

8

Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function.

Jacobson MA, Khayam-Bashi H, Martin JN, Black D, Ng V. Jacobson MA, et al. Among authors: martin jn. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):472-7. doi: 10.1097/00126334-200212150-00003. J Acquir Immune Defic Syndr. 2002. PMID: 12473834 Clinical Trial.

9

Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.

Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Porco TC, et al. Among authors: martin jn. AIDS. 2004 Jan 2;18(1):81-8. doi: 10.1097/00002030-200401020-00010. AIDS. 2004. PMID: 15090833 Free PMC article.

10

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.

Deeks SG, Hoh R, Neilands TB, Liegler T, Aweeka F, Petropoulos CJ, Grant RM, Martin JN. Deeks SG, et al. Among authors: martin jn. J Infect Dis. 2005 Nov 1;192(9):1537-44. doi: 10.1086/496892. Epub 2005 Sep 20. J Infect Dis. 2005. PMID: 16206068 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters